Biosynth are Proud to be at the Forefront of Peptide Science. 

Kevin Robinson of Manufacturing Chemist Magazine talks to our experts Peter Timmerman , Chief Scientific Officer, Peptides, and Ehab Alramahy, Head of Peptide Division, about this market and how Biosynth has built a peptide supply division to support drug development companies. Focused on the entire peptide research, development and commercialisation process, across global sites, we offer the flexibility to meet the needs of those developing novel peptide-based treatments and diagnostics.

Read our the full interview and article here 

                                                     

 Ehab Alramahy and Peter Timmerman

Interviewed by Manufacturing Chemist Magazine 

Leave a Reply